Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgG with Reflex to Type 1 and 2 Glycoprotein G-Specific Ab, IgG
Also known as: HERPR PAN2
Use
This test is preferred for detecting herpes simplex virus (HSV) when exposure is suspected. It can be useful in identifying subclinical HSV infections. If results are positive for HSV type 1/2 combined antibodies but negative for both type-specific antibodies, a follow-up test is recommended after at least one month, as glycoprotein antibodies may require 3-6 months to form.
Special Instructions
Parallel testing is preferred. Convalescent specimens must be received within 30 days of acute specimens. Specimens must be clearly marked as 'acute' or 'convalescent.' If HSV 1 and/or 2 IgG is 1.10 IV or greater, then HSV 1 gG-Specific IgG and HSV 2 gG-Specific IgG will be added, with additional charges.
Limitations
False-positive results for HSV antibodies are possible. For the most accurate diagnosis, a significant change should be observed on two appropriately timed specimens, both done at the same laboratory. If the result for HSV-2 is less than or equal to 3.0 IV, additional testing for HSV-2 should be considered.
Methodology
Immunoassay (CLIA)
Biomarkers
LOINC Codes
- 27948-9
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
ARUP standard transport tube
Collection Instructions
Collect in a serum separator tube. Mark specimens plainly as 'acute' or 'convalescent.'
Causes for Rejection
Plasma or urine. Contaminated, heat-inactivated, hemolyzed, icteric, or severely lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year |
Other tests from different labs that may be relevant
